146 related articles for article (PubMed ID: 2846948)
1. [Modification of atrial natriuretic peptide (ANP) and cyclic GMP by hemofiltration and hemodialysis].
Eisenhauer T; Talartschik J; Quentin E; Kreutzfeldt W; Scheler F
Klin Wochenschr; 1988 Sep; 66(18):940-5. PubMed ID: 2846948
[TBL] [Abstract][Full Text] [Related]
2. [Is the plasma ANP level an index of volume expansion in dialysis patients?].
Talartschik J; Eisenhauer T; Voth E; Sold G; Scheler F
Z Kardiol; 1988; 77 Suppl 2():72-7. PubMed ID: 2970178
[TBL] [Abstract][Full Text] [Related]
3. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD.
Plum J; Ziyaie M; Kemmer FW; Passlick-Deetjen J; Grabensee B
Adv Perit Dial; 1990; 6():211-9. PubMed ID: 1982811
[TBL] [Abstract][Full Text] [Related]
4. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
6. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure.
Eisenhauer T; Talartschik J; Scheler F
Klin Wochenschr; 1986; 64 Suppl 6():68-72. PubMed ID: 2948067
[TBL] [Abstract][Full Text] [Related]
7. Association between atrial natriuretic peptide and cyclic GMP in hypertension and in chronic renal failure.
Sagnella GA; Saggar-Malik AK; Buckley MG; Markandu ND; Eastwood JB; MacGregor GA
Clin Chim Acta; 1998 Jul; 275(1):9-18. PubMed ID: 9706839
[TBL] [Abstract][Full Text] [Related]
8. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
Franz M; Woloszczuk W; Hörl WH
Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
Elias AN; Vaziri ND; Pandian MR; Kaupke J
Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide plasma levels during hemodialysis and hemofiltration in patients with end-stage renal disease.
Groll J; Hagemann J; Röhrich B; Schaefer K
Int J Artif Organs; 1989 May; 12(5):284-8. PubMed ID: 2525530
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
Kohse KP; Feifel K; Mayer-Wehrstein R
Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
[TBL] [Abstract][Full Text] [Related]
12. Plasma atrial natriuretic peptide in patients with chronic renal failure.
Chen JH; Tsai JH; Lai YH; Hwang SJ
J Formos Med Assoc; 1990 Aug; 89(8):645-50. PubMed ID: 1981224
[TBL] [Abstract][Full Text] [Related]
13. The mature form of adrenomedullin correlates with brain natriuretic peptide in plasma of chronic hemodialysis patients.
Suda T; Osajima A; Iwamoto M; Anai H; Tamura M; Kabashima N; Ota T; Watanabe Y; Kanegae K; Okazaki M; Nakashima Y
Clin Nephrol; 2002 Jun; 57(6):444-51. PubMed ID: 12078948
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.
Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W
Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187
[TBL] [Abstract][Full Text] [Related]
15. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
Haug C; Metzele A; Steffgen J; Grünert A
Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
[TBL] [Abstract][Full Text] [Related]
16. Plasma atrial natriuretic factor (alpha ANF) during hemodialysis (HD) and hemofiltration (HF).
Alarabi AA; Hansell P; Wikström B; Danielson BG
Scand J Urol Nephrol; 1991; 25(1):65-9. PubMed ID: 1828611
[TBL] [Abstract][Full Text] [Related]
17. Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.
Heintz B; Königs F; Dakshinamurty KV; Kierdorf H; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H
Nephron; 1993; 65(2):266-72. PubMed ID: 8247191
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis.
Bald M; Bonzel KE; Rascher W
Clin Nephrol; 1994 Jul; 42(1):50-3. PubMed ID: 7923967
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis.
Plum J; Grabensee B
J Intern Med; 1991 Mar; 229(3):209-16. PubMed ID: 1826125
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.
Hasegawa K; Matsushita Y; Inoue T; Morii H; Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
